ATE332901T1 - Spirocyclische 6,7-dihydro-5h-pyrazoloc1,2- a)pyrazol-1-one, die inflammatorische cytokine steuern - Google Patents

Spirocyclische 6,7-dihydro-5h-pyrazoloc1,2- a)pyrazol-1-one, die inflammatorische cytokine steuern

Info

Publication number
ATE332901T1
ATE332901T1 AT02799017T AT02799017T ATE332901T1 AT E332901 T1 ATE332901 T1 AT E332901T1 AT 02799017 T AT02799017 T AT 02799017T AT 02799017 T AT02799017 T AT 02799017T AT E332901 T1 ATE332901 T1 AT E332901T1
Authority
AT
Austria
Prior art keywords
pyrazoloc1
spirocyclic
pyrazol
dihydro
inflammatory cytokine
Prior art date
Application number
AT02799017T
Other languages
English (en)
Inventor
Matthew John Laufersweiler
Michael Phillip Clark
Jane Far-Jine Djung
Adam Golebiowski
Biswanath De
Todd Andrew Brugel
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE332901T1 publication Critical patent/ATE332901T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20Spiro-condensed systems
AT02799017T 2001-09-20 2002-09-20 Spirocyclische 6,7-dihydro-5h-pyrazoloc1,2- a)pyrazol-1-one, die inflammatorische cytokine steuern ATE332901T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32362501P 2001-09-20 2001-09-20

Publications (1)

Publication Number Publication Date
ATE332901T1 true ATE332901T1 (de) 2006-08-15

Family

ID=23259997

Family Applications (3)

Application Number Title Priority Date Filing Date
AT02763693T ATE356126T1 (de) 2001-09-20 2002-09-20 6,7-dihydro-5h-pyrazolo-1,2-aö pyrazol-1-one zur kontrolle von entzündungsfördernden cytokinen
AT02799017T ATE332901T1 (de) 2001-09-20 2002-09-20 Spirocyclische 6,7-dihydro-5h-pyrazoloc1,2- a)pyrazol-1-one, die inflammatorische cytokine steuern
AT02763692T ATE287887T1 (de) 2001-09-20 2002-09-20 Verbindungen, welche die freisetzung von cytokinen inhibieren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT02763693T ATE356126T1 (de) 2001-09-20 2002-09-20 6,7-dihydro-5h-pyrazolo-1,2-aö pyrazol-1-one zur kontrolle von entzündungsfördernden cytokinen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT02763692T ATE287887T1 (de) 2001-09-20 2002-09-20 Verbindungen, welche die freisetzung von cytokinen inhibieren

Country Status (33)

Country Link
US (2) US6821971B2 (de)
EP (3) EP1427728B1 (de)
JP (3) JP2005504081A (de)
KR (4) KR20040035837A (de)
CN (3) CN1257905C (de)
AR (3) AR037145A1 (de)
AT (3) ATE356126T1 (de)
AU (2) AU2002334641B2 (de)
BR (3) BR0212905A (de)
CA (3) CA2461071A1 (de)
CO (3) CO5560590A2 (de)
CY (1) CY1106398T1 (de)
CZ (3) CZ2004361A3 (de)
DE (3) DE60202782T2 (de)
DK (2) DK1427732T3 (de)
EG (2) EG24363A (de)
ES (3) ES2282459T3 (de)
HK (2) HK1071366A1 (de)
HU (3) HUP0402500A3 (de)
IL (3) IL160682A0 (de)
MA (3) MA27064A1 (de)
MX (3) MXPA04002574A (de)
MY (2) MY129329A (de)
NO (2) NO20041594L (de)
NZ (3) NZ531063A (de)
PE (3) PE20030474A1 (de)
PL (3) PL370362A1 (de)
PT (3) PT1427727E (de)
RU (3) RU2299885C2 (de)
SA (1) SA03230529B1 (de)
SK (3) SK1482004A3 (de)
WO (3) WO2003024971A1 (de)
ZA (3) ZA200401260B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7087615B2 (en) 2001-09-20 2006-08-08 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia
US6849627B2 (en) 2001-09-20 2005-02-01 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7473695B2 (en) 2001-10-22 2009-01-06 Mitsubishi Tanabe Pharma Corporation 4-imidazolin-2-one compounds
US6677337B2 (en) * 2002-03-19 2004-01-13 The Procter & Gamble Company 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
ATE355839T1 (de) * 2002-09-09 2007-03-15 Amgen Inc 1,4,5-substituierte 1,2-dihydro-pyrazol-3-one and 3-alkoxy-1h-pyrazole derivate als tnf-alpha und interleukin senkende wirkstoffe zur behandlung von entzündungen
ES2285444T3 (es) * 2003-04-03 2007-11-16 Merck Patent Gmbh Derivados de la 1-(fenil)-amida)-2-(fenil)-amida) del acido pirazolidin-1,2-dicarboxilico como inhibidores del factor de coagulacion xa para el tratamiento de la trombosis.
GB0308466D0 (en) * 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US7482356B2 (en) * 2003-11-10 2009-01-27 The Procter & Gamble Company Bicyclic pyrazolone cytokine inhibitors
RU2450006C2 (ru) * 2006-04-18 2012-05-10 Эбботт Лэборетриз Антагонисты ванилоидного рецептора подтипа 1(vr1) и их применение
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
RU2011151603A (ru) * 2009-05-19 2013-06-27 ДАУ АГРОСАЙЕНСИЗ ЭлЭсСи Соединения и способы борьбы с грибами
EP3308059B1 (de) 2015-06-15 2021-05-26 Cummins, Inc. Brennraumelastizitätsvorrichtung
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods
CN107033090B (zh) * 2017-05-16 2019-05-07 无锡捷化医药科技有限公司 一种1,2,3,4-四氢噌啉的制备方法
RU2721684C1 (ru) * 2019-09-06 2020-05-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" Метил 2,3,8-триоксо-4-фенилтетрагидро-6Н-пиразоло[1,2-а]пирроло[2,3-c]пиразол-9а(1Н)-карбоксилаты
WO2023076133A1 (en) * 2021-10-27 2023-05-04 Merck Sharp & Dohme Llc Spirotricycle ripk1 inhibitors and methods of uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054291A (de) 1963-02-26
GB1124982A (en) * 1965-02-09 1968-08-21 Lepetit Spa Diazabicyclo octanes and derivatives thereof
CH529154A (fr) 1969-10-27 1972-10-15 Lepetit Spa Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones
US5358924A (en) * 1991-03-21 1994-10-25 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrozoline derivatives, compositions and use
RU2269537C2 (ru) * 1999-09-07 2006-02-10 Зингента Партисипейшнс Аг Фенилзамещенные гетероциклические 1,3-кетоенолы, способ их получения, гербицидное средство на их основе и способ борьбы с ростом нежелательной растительности
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Also Published As

Publication number Publication date
ES2282459T3 (es) 2007-10-16
IL160741A0 (en) 2004-08-31
PE20030430A1 (es) 2003-06-24
BR0212716A (pt) 2004-08-03
KR20040035836A (ko) 2004-04-29
EP1427728A1 (de) 2004-06-16
CN1250551C (zh) 2006-04-12
MXPA04002570A (es) 2004-05-31
JP2005504081A (ja) 2005-02-10
CA2461072A1 (en) 2003-03-27
EP1427727A1 (de) 2004-06-16
CO5560579A2 (es) 2005-09-30
US6821971B2 (en) 2004-11-23
DE60213108D1 (de) 2006-08-24
RU2272040C2 (ru) 2006-03-20
SA03230529B1 (ar) 2008-06-21
AU2002334641B2 (en) 2007-03-29
DE60202782T2 (de) 2006-01-19
WO2003024971A1 (en) 2003-03-27
WO2003024973A1 (en) 2003-03-27
ES2268154T3 (es) 2007-03-16
RU2004111805A (ru) 2005-04-10
EP1427728B1 (de) 2007-03-07
CN1249066C (zh) 2006-04-05
AR037237A1 (es) 2004-11-03
PT1427728E (pt) 2007-05-31
HUP0402500A2 (hu) 2005-03-29
CY1106398T1 (el) 2011-10-12
HUP0402500A3 (en) 2008-10-28
US20030105084A1 (en) 2003-06-05
HUP0500752A2 (en) 2006-01-30
KR100623879B1 (ko) 2006-09-19
US6566357B1 (en) 2003-05-20
PL370362A1 (en) 2005-05-16
AR037502A1 (es) 2004-11-17
DE60202782D1 (de) 2005-03-03
PE20030474A1 (es) 2003-07-22
KR20040035835A (ko) 2004-04-29
IL160742A0 (en) 2004-08-31
SK1502004A3 (en) 2004-09-08
BR0212673A (pt) 2004-08-24
JP2005504082A (ja) 2005-02-10
DK1427728T3 (da) 2007-07-09
ZA200401402B (en) 2004-08-27
ATE356126T1 (de) 2007-03-15
NO20041594L (no) 2004-06-21
PE20030446A1 (es) 2003-07-21
PL370415A1 (en) 2005-05-30
EP1427732B1 (de) 2006-07-12
HUP0402378A2 (hu) 2005-02-28
CA2461071A1 (en) 2003-03-27
NZ531063A (en) 2007-08-31
CN1257905C (zh) 2006-05-31
PT1427732E (pt) 2006-12-29
DE60218704D1 (de) 2007-04-19
MXPA04002574A (es) 2004-06-18
MA27064A1 (fr) 2004-12-20
MXPA04002569A (es) 2004-05-31
JP2005504083A (ja) 2005-02-10
WO2003024970A1 (en) 2003-03-27
AR037145A1 (es) 2004-10-27
IL160682A0 (en) 2004-08-31
ES2237691T3 (es) 2005-08-01
EG24363A (en) 2009-03-04
MA27066A1 (fr) 2004-12-20
RU2004111806A (ru) 2005-03-27
CZ2004345A3 (cs) 2004-06-16
ZA200401403B (en) 2004-08-30
CO5560590A2 (es) 2005-09-30
HK1071565A1 (en) 2005-07-22
RU2278864C2 (ru) 2006-06-27
NZ531122A (en) 2005-09-30
EP1427727B1 (de) 2005-01-26
PL370351A1 (en) 2005-05-16
RU2299885C2 (ru) 2007-05-27
ATE287887T1 (de) 2005-02-15
HUP0402378A3 (en) 2008-10-28
DE60218704T2 (de) 2007-11-08
CN1555375A (zh) 2004-12-15
NO20041605L (no) 2004-06-21
CZ2004361A3 (cs) 2004-07-14
HK1071366A1 (en) 2005-07-15
NZ531123A (en) 2006-08-31
EG24413A (en) 2009-05-25
CO5560589A2 (es) 2005-09-30
KR20060036125A (ko) 2006-04-27
EP1427732A1 (de) 2004-06-16
DE60213108T2 (de) 2007-02-08
ZA200401260B (en) 2004-08-30
CZ2004358A3 (cs) 2004-07-14
SK1482004A3 (en) 2004-08-03
BR0212905A (pt) 2004-10-13
MY129069A (en) 2007-03-30
MA27065A1 (fr) 2004-12-20
RU2004111803A (ru) 2005-10-10
AU2002327690B2 (en) 2006-07-20
SK1492004A3 (en) 2004-11-03
CN1556811A (zh) 2004-12-22
KR100656126B1 (ko) 2006-12-12
PT1427727E (pt) 2005-06-30
CN1555379A (zh) 2004-12-15
MY129329A (en) 2007-03-30
KR20040035837A (ko) 2004-04-29
DK1427732T3 (da) 2006-10-30
CA2461073A1 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
ATE332901T1 (de) Spirocyclische 6,7-dihydro-5h-pyrazoloc1,2- a)pyrazol-1-one, die inflammatorische cytokine steuern
NO2017014I1 (no) 6-acetyl-8-cyclopentyl-5-metyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-on
NO20035476D0 (no) Azaindoler
DE60218501D1 (de) Einstellbarer fixateur
DE60216774D1 (de) Abgasreinigungsvorrichtung
NO20042474L (no) Reguleringsventil-stromningsjusteringsanordning.
DK1608654T3 (da) 8-substituerede-6, 7, 8, 9-tetrahydropyrimido (1,2- a) pyrimidin-4-on-derivater
DK1608653T3 (da) Substituerede 8-perfluoroalkyl-6,7,8,9- tetrahydropyrimido (1,2-a) pyrimidin-4-on derivater
DE50208025D1 (de) Steuervorrichtung
DE60205921D1 (de) SUBSTITUIERTE 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDOç1,2-A!PYRIMIDIN-4-ON- UND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO-ç1,2-A!PYRIMIDIN-5(1H)ONDERIVATE
ATE326467T1 (de) Imidazo 1,2-aöpyridine
DK1399355T3 (da) Styringsenhed
DE60222937D1 (de) Schubsteuervorrichtung
DE60142184D1 (de) Bewegliches körpersystem
ITMI20021835A1 (it) Apparecchio di comando
FI20011518A0 (fi) Liikeanalysaattori
IS6933A (is) Veirueyðandi samsetningar
DE50105245D1 (de) Manuell bewegbarer Gurthobel
FR2821754B1 (fr) Descenceur autobloquant
DE50201979D1 (de) Hydraulische Steuereinrichtung
DE50204799D1 (de) Rückenlehne
DE50207525D1 (de) Steuervorrichtung
NO20033189L (no) Kontrollmidler
DE60225626D1 (de) altung mit die Versorgungsspannung überschreitenden Auslösepunkten
ES1049419Y (es) Luminaria de emergencia perfeccionada.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1427732

Country of ref document: EP

REN Ceased due to non-payment of the annual fee